AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Short-term Investments

Marketable securities and deposits the company expects to convert to cash within a year.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Short-term Investments · Q3 FY2025 · quarter ended Sep 2025

Short-term investments of €0 in Q3 FY2025

Q3 FY2025 short-term investments was €0.

Context

  • Short-term investments amounted to 0.0% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€0— QoQ
Short-term Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Short-term Investments history

Currency unavailable · from the balance sheet

No Short-term Investments data reported for this period type.

Short-term Investments vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so short-term investments is compared through growth and share of total assets rather than absolute size.
  • Short-term investments amounts to 0.0% of total assets for AGMB, versus a peer median of 25.1%.
AGMB Competitors
Short-term Investments for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALMSAlumis Inc. Common StockJun 2026$438.59M USD+31.1%+48.2%78.2%
ACRSAclaris Therapeutics, Inc.Mar 2026$76.76M USD+2.4%-25.7%38.6%
ANABAnaptysBio, Inc.Mar 2026$37.99M USD-84.3%-41.7%11.5%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€0 EUR——0.0%
EQEquillium, Inc.Mar 2026$0 USD——0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —+2.4%-25.7%25.1%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.